Provided by Tiger Trade Technology Pte. Ltd.

AC Immune SA

2.81
+0.19007.25%
Post-market: 2.76-0.0500-1.78%19:30 EDT
Volume:352.70K
Turnover:965.12K
Market Cap:285.98M
PE:-5.34
High:2.84
Open:2.64
Low:2.57
Close:2.62
52wk High:4.00
52wk Low:2.10
Shares:101.77M
Float Shares:39.19M
Volume Ratio:1.58
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5264
EPS(LYR):-0.8828
ROE:-78.53%
ROA:-16.04%
PB:6.74
PE(LYR):-3.18

Loading ...

Top Executive Move at AC Immune SA Sparks Fresh Investor Buzz

TIPRANKS
·
May 19

AC Immune CEO Andrea Pfeifer sells 10,000 shares worth $27,940

Reuters
·
May 19

AC Immune CEO Pfeifer retires; Chair Zügel becomes interim CEO

Reuters
·
May 12

AC Immune Announces Retirement of CEO DR Andrea Pfeifer at Upcoming AGM

THOMSON REUTERS
·
May 12

AC Immune Sa - Appoints Martin ZÜGel as Interim CEO

THOMSON REUTERS
·
May 12

AC Immune Price Target Maintained With a $8.00/Share by BTIG

Dow Jones
·
May 04

AC Immune SA reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Apr 30

AC Immune Q1 EPS $(0.19) Beats $(0.20) Estimate, Sales $1.429M Beat $1.000M Estimate

Benzinga Earnings
·
Apr 30

AC Immune Q1 net loss narrows 22.2% to CHF 14.8 million

Reuters
·
Apr 30

AC Immune Q1 Net Income CHF -14.8 Million

THOMSON REUTERS
·
Apr 30

AC Immune First Quarter 2026 Financial and Corporate Updates

THOMSON REUTERS
·
Apr 30

AC Immune starts final ABATE trial cohort testing ACI-24 Alzheimer’s vaccine candidate

Reuters
·
Apr 30

AC Immune CEO Andrea Pfeifer buys 10,000 shares worth $31,425

Reuters
·
Apr 16

Analysts Are Bullish on Top Healthcare Stocks: Insmed (INSM), AC Immune SA (ACIU)

TIPRANKS
·
Apr 08

Leerink calls AC Immune- Eli Lilly Tau amendment ‘great news’

TIPRANKS
·
Apr 08

AC Immune Extends Alzheimer's Drug Pact With Eli Lilly

Dow Jones
·
Apr 07

AC Immune announces amendment to Eli Lilly license pact, to receive CHF 10M

TIPRANKS
·
Apr 07

AC Immune Sa - Under Amendment, Co to Receive CHF10 Mln Upfront Payment and Phase 1 Milestone Payment

THOMSON REUTERS
·
Apr 07

AC Immune Sa - Ind-Enabling Studies to Commence in H1 2026

THOMSON REUTERS
·
Apr 07

AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement With Lilly

THOMSON REUTERS
·
Apr 07